Studies have reported improved quality of life after lung and heart-lung transplants. One study showed that at the two-year follow-up period, 86% of studied recipients reported no limitation to their activity.
Their ability to survive the surgery and the difficult recovery period, as well as their longterm prognosis, is hindered by their conditions.
Patients who are limited in daily activity, as defined by their doctors, and have a limited life expectancy, are candidates for heart-lung transplantation. These patients suffer from untreatable end-stage pulmonary, organ, and/or vascular disease.
About 95% of lung abscess patients can be treated successfully with antibiotics alone. Patients who need surgical treatment have a mortality rate of 10-15%.
Well, when you get a lung transplantation it IS helping you. It helps you because lungs=you breathing. So when you get a lung transplantation it is REALLY helping you breath.
Patients with advanced heart and lung disease, who are human immunodeficiency virus (HIV) positive,
Type B patients generally live to adulthood but suffer from significant liver and lung problems.
Most patients with mild or moderate heart failure can be successfully treated with dietary and exercise programs and the right medications.
The prognosis for TGA patients is excellent
Patients with NPD-A commonly die during infancy. NPD-B patients may live for a few decades, but many require supplemental oxygen because of lung impairment.
The purpose of lung transplantation is to replace a lung that no longer functions with a healthy lung. To perform a lung transplantation, there should be potential for rehabilitated breathing function
Patients receiving a pancreas transplantation are monitored closely for organ rejection.
The prognosis for TGA patients is excellent